Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Stem Cells and Tissue Regeneration

Stem cell therapy for autoimmune disease: overview of concepts from the Snowbird 2002 tolerance and tissue regeneration meeting

Bone Marrow Transplantation volume 32, pages S3–S5 (2003)Cite this article

Summary:

Hematopoietic stem cell transplantation as a treatment for autoimmune disease began in 1996 and has subsequently spread worldwide. In Europe phase III trials have opened, while in America phase III trials are being designed and funded by the National Institutes of Health. On 6 June 2002, clinicians and scientists from around the world met at Snowbird, Utah to discuss the results and future directions of stem cell therapy for autoimmune diseases. What follows are general concepts from chairpersons of this meeting.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. McSweeney PA, Nash RA, Sullivan KM et al. High-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomes. Blood 2002; 100: 1602–1610.

    CAS  PubMed  Google Scholar 

  2. Sondel PM . The graft-versus-leukemia effect. In: Barrett J, Jiang Y-Z (eds). Allogeneic Immunotherapy for Malignant Disease. Delker: New York, 2000, pp 1–12.

    Google Scholar 

  3. Appelbaum FR . Hematopoietic stem cell transplantation as immunotherapy. Nat Med 2001; 411: 385–389.

    CAS  Google Scholar 

  4. Hinterberger W, Hinterberger-Fischer M, Marmont AM . Clinically demonstrable anti-autoimmunity mediated by Q2allogeneic immune cells favourably affects outcomes after stem cell transplantation in human autoimmune diseases. Bone Marrow Transplant 2002; 30: 753–759.

    Article  CAS  PubMed  Google Scholar 

  5. Slavin S, Nagler A, Varadi G, Or R . Graft vs autoimmunity following allogeneic non-myeloablative blood stem cell transplantation in a patient with chronic myelogenous leukaemia and severe psoriasis and psoriatic polyarthritis. Exp Hematol 2000; 28: 853–857.

    Article  CAS  PubMed  Google Scholar 

  6. Burt RK, Slavin S, Burns WH, Marmont AM . Induction of tolerance in autoimmune diseases by hematopoietic stem cell transplantation: getting closer to a cure? Blood 2002; 99: 768–784.

    Article  CAS  PubMed  Google Scholar 

  7. Bevan MJ, Hogquist KA, Jameson SC . Selecting the T cell receptor repertoire. Science 1994; 264: 796–797.

    Article  CAS  PubMed  Google Scholar 

  8. Ashton-Rickardt PG, Tonegawa S . A differential-avidity model for T-cell selection. Immunol Today 1994; 15: 362–366.

    Article  CAS  PubMed  Google Scholar 

  9. Sebzda E, Wallace VA, Mayer J et al. Positive and negative thymocyte selection induced by different concentrations of a single peptide. Science 1994; 263: 1615–1618.

    Article  CAS  PubMed  Google Scholar 

  10. Tyndall A, Fassas A, Passweg J et al. Autologous haematopoietic stem cell transplants for autoimmune disease – feasibility and transplant-related mortality. Autoimmune Disease and Lymphoma Working Parties of the European Group for Blood and Marrow Transplantation, the European League Against Rheumatism and the International Stem Cell Project for Autoimmune Disease. Bone Marrow Transplant 1999; 24: 729–734.

    Article  CAS  PubMed  Google Scholar 

  11. Moore J, Brooks P, Milliken S et al. A pilot randomized trial comparing CD34-selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritis. Arthritis Rheum 2002; 46: 2301–2309.

    Article  CAS  PubMed  Google Scholar 

  12. Traynor AE, Barr WG, Rosa RM et al. Hematopoietic stem cell transplantation for severe and refractory lupus. Analysis after five years and fifteen patients. Arthritis Rheum 2002; 46: 2917–2923.

    Article  PubMed  Google Scholar 

  13. O'Dell JR, Steigerwald JC, Kennaugh RC et al. Lack of clinical benefit after treatment of systemic sclerosis with total lymphoid irradiation. J Rheumatol 1989; 16: 1050–1054.

    CAS  PubMed  Google Scholar 

  14. The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Breast radiotherapy after breast-conserving surgery. Canadian Association of Radiation Oncologists. CMAJ 1998; 158 (Suppl. 3): S35–S42.

  15. Kocher AA, Schuster MD, Szabolcs MJ et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 2001; 7: 430–436.

    Article  CAS  PubMed  Google Scholar 

  16. Orlic D, Kajstura J, Chimenti S et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001; 410: 701–705.

    Article  CAS  PubMed  Google Scholar 

  17. Petersen BE, Bowen WC, Patrene KD et al. Bone marrow as a potential source of hepatic oval cells. Science 1999; 284: 1168–1170 (Journal Article).

    Article  CAS  PubMed  Google Scholar 

  18. Mezey E, Chandross KJ, Harta G et al. Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow [Journal Article]. Science. 2000; 290: 1779–1782 (Comment).

    Article  CAS  PubMed  Google Scholar 

  19. Korbling M, Katz RL, Khanna A et al. Hepatocytes and epithelial cells of donor origin in recipients of peripheral-blood stem cells. N Engl J Med 2002; 346: 738–746.

    Article  PubMed  Google Scholar 

  20. Krause DS, Theise ND, Collector MI et al. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 2001; 105: 369–377.

    Article  CAS  PubMed  Google Scholar 

  21. Terada N, Hamazaki T, Oka M et al. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 2002; 416: 542–545.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Northwestern University Medical Center, Chicago, IL, USA

    R K Burt & Y Oyama

  2. University Hospital Charite, Berlin, Germany

    R Arnold

  3. University of Massachusetts, USA

    R Emmons

  4. Bone Marrow and Blood Transplantation Center, S Martino's Hospital, Genoa, Italy

    A Marmont

Authors
  1. R K Burt
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R Arnold
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R Emmons
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Y Oyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A Marmont
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to R K Burt.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Burt, R., Arnold, R., Emmons, R. et al. Stem cell therapy for autoimmune disease: overview of concepts from the Snowbird 2002 tolerance and tissue regeneration meeting. Bone Marrow Transplant 32 (Suppl 1), S3–S5 (2003). https://doi.org/10.1038/sj.bmt.1703935

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1703935

Keywords

This article is cited by

Search

Advanced search

Quick links